Hyperpigmentation Disorders Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Jul 2018| TMR741A| Transparency

Report Highlights

Global Hyperpigmentation Disorders Treatment Market: Overview
This report analyzes the global hyperpigmentation disorders treatment market in terms of its current and future scenario. Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of hyperpigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the growth of the global market during the forecast period. Anti-pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

This report on the global hyperpigmentation disorders treatment market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global hyperpigmentation disorders treatment market.

Global Hyperpigmentation Disorders Treatment Market: Key Segments
The global hyperpigmentation disorders treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others, based on treatment type. By disease indication, the market has been classified into melasma, post-inflammatory hyperpigmentation, solar lentigines, and others. In terms of end-user, the market has been segmented into hospitals, aesthetic clinics & dermatology centers, and others. The global hyperpigmentation disorders treatment market has been analyzed based on increasing prevalence of hyperpigmentation disorders, technology trend, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.

Global Hyperpigmentation Disorders Treatment Market: Regional Outlook
Geographically, the global hyperpigmentation disorders treatment market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, viz. 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report
The report profiles the major players operating in the global hyperpigmentation disorders treatment market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma.

The global hyperpigmentation disorders treatment market has been segmented as follows:

Hyperpigmentation Disorders Treatment Market, by Treatment Type
Topical Drugs
Laser Therapy
Chemical Peels
Microdermabrasion
Phototherapy
Others

Hyperpigmentation Disorders Treatment Market, by Disease Indication
Melasma
Post-inflammatory Hyperpigmentation
Solar Lentigines
Others

Hyperpigmentation Disorders Treatment Market, by End-user
Hospitals
Aesthetic Clinics & Dermatology Centers
Others

Hyperpigmentation Disorders Treatment Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia-pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 2 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 3 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 4 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 5 : North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 6 : North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 7 : North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 8 : North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 9 : Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 10 : Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 11 : Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 12 : Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 13 : Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 14 : Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 15 : Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 16 : Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 17 : Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 18 : Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 19 : Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 20 : Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 21 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 23 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 24 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 25 : Bayer AG Business Overview
  • Table 26 : Allergan Business Overview
  • Table 27 : Galderma S.A. Business Overview
  • Table 28 : SkinCeuticals Business Overview
  • Table 29 : Pierre Fabre Business Overview
  • Table 30 : EpiPharm AG Business Overview
  • Table 31 : RXi Pharmaceuticals Corporation Business Overview
  • Table 32 : Obagi Cosmeceuticals LLC Business Overview
  • Table 33 : Vivier Pharma Business Overview
  • Figure 1 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 3 : Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017
  • Figure 4 : Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
  • Figure 5 : Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017
  • Figure 6 : Hyperpigmentation Disorders Treatment Market Value Share, by Region, 2017
  • Figure 7 : Global Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 8 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
  • Figure 9 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
  • Figure 10 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
  • Figure 11 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
  • Figure 12 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2016–2026
  • Figure 13 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 14 : Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
  • Figure 15 : Global Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 16 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2016–2026
  • Figure 17 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2016–2026
  • Figure 18 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Solar Lentigines, 2016–2026
  • Figure 19 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 20 : Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
  • Figure 21 : Global Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 22 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
  • Figure 23 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
  • Figure 24 : Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 25 : Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
  • Figure 26 : Global Hyperpigmentation Disorders Treatment Market Value Share, by Region, 2017 and 2026
  • Figure 27 : Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 28 : North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 29 : North America Hyperpigmentation Disorders Treatment Market Value Share, by Country, 2017 and 2026
  • Figure 30 : North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
  • Figure 31 : North America Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 32 : North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
  • Figure 33 : North America Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 34 : North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 35 : North America Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 36 : North America Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 37 : Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 38 : Europe Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 39 : Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 40 : Europe Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 41 : Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 42 : Europe Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 43 : Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 44 : Europe Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 45 : Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 46 : Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 47 : Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 48 : Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 49 : Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 50 : Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
  • Figure 51 : Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 52 : Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 53 : Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 54 : Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 55 : Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 56 : Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 57 : Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 58 : Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 59 : Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
  • Figure 60 : Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 61 : Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 62 : Latin America Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 63 : Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 64 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 65 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 66 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 67 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 68 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 69 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 70 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 71 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 72 : Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report